Trinity Biotech PLC (fra:TRB) Share Price

Company Profile

Business description
Trinity Biotech PLC is in the business of developing, manufacturing, and marketing clinical diagnostic products for clinical laboratory and point-of-care sections of the diagnostic market. Its products are used to detect autoimmune, infectious, sexually transmitted diseases, diabetes, and disorders of the liver and intestine. The company also provides raw materials to the life sciences and research industries globally. It markets products under the brand names Recombigen, Unigold, MarBlot, Mardx, Immublot, and others. Geographically, it has two segments namely the Americas, and the Rest of World - Ireland from which it derives a majority of its revenue from the Americas segment.
Contact
IDA Business Park
Bray, County Wicklow
DublinA98 H5C8
IRL
T: +353 12769800
E: [email protected]
https://www.trinitybiotech.com
Sector
Healthcare
Stock type
Defensive
Industry
Medical Devices
Fiscal Year End
31 December 2025
Employees
380

Recommended

After a historic rally in 2024, what lies ahead for this overvalued banking titan?

Simonelle Mody | 13 March 2025

The global education services provider has gone from stock market darling to one of the ASX's weakest performers. What gives?

Joseph Taylor | 12 March 2025

After the recent selloff, the bull market’s most in-demand stocks look much cheaper.

Sarah Hansen | 12 March 2025

Index	Last price	Change	% Change
All Ordinaries	8,013.30	46.70	0.59%
CAC 40	7,938.21	50.75	-0.64%
DAX 40	22,567.14	109.27	-0.48%
Dow JONES (US)	40,813.57	537.36	-1.30%
FTSE 100	8,542.56	1.59	0.02%
HKSE	24,039.04	576.39	2.46%
NASDAQ	17,303.01	345.44	-1.96%
Nikkei 225	37,053.10	263.07	0.72%
NZX 50 Index	12,266.25	57.20	0.47%
S&P 500	5,521.52	77.78	-1.39%
S&P/ASX 200	7,789.70	40.60	0.52%
SSE Composite Index	3,418.05	59.32	1.77%